Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHISX vs. JDOC: which is better?

Bottom line

SHISX vs JDOC: the short answer

SHISX (Blackrock Health Sciences Opportunities Portfolio) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.

But SHISX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

JDOC is cheaper at 0.65% vs 1.16% — a difference of $51 a year per $10,000 invested.

Over one year, SHISX returned +15.9% vs +14.9% for JDOC.

Updated Nov 19, 2026

SHISX vs JDOC side by side

SHISXJDOC
TypeMutual fundETF
Fund familyBlackRockJ.P. Morgan
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.16%0.65%
Annual cost per $10k$116$65
10-yr cost on $10k (prospectus)$1,409$810
Max front load—None
12b-1 fee0.25%—
1-yr return+15.9%+14.9%
5-yr return (annualized)+5.5%—
10-yr return (annualized)+9.5%—
Best quarter+17.5%+11.3%
Worst quarter−11.5%−11.9%
Net assets (fund)$5.9B$9.1M
Number of holdings15561
Portfolio turnover49%92%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHISXJDOCDifference
2025+15.9%+14.9%+1.0%
2024+3.8%−0.6%+4.4%

Source: Fund prospectus bar charts

Holdings overlap

14 of SHISX's top 25 holdings also appear in JDOC's top 25.

Shared top holdings
HoldingSHISXJDOC
Eli Lilly & Company12.29%7.76%
Johnson & Johnson8.77%4.82%
Unitedhealth Group Inc6.10%5.85%
Merck & Company Inc4.94%4.82%
Abbvie Inc3.94%7.85%
Thermo Fisher Scientific Inc3.02%3.73%
Edwards Lifesciences Corp2.51%1.73%
Danaher Corp2.00%2.16%
Abbott Laboratories1.97%3.11%
Intuitive Surgical Inc1.95%1.93%
Biogen Inc1.21%1.56%
Astrazeneca Plc1.21%3.76%
Stryker Corp1.15%2.23%
Regeneron Pharmaceuticals Inc0.91%1.60%

Source: SEC Form N-PORT

SHISX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

FAQ

What is the difference between SHISX and JDOC?
SHISX (Blackrock Health Sciences Opportunities Portfolio) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds. But SHISX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, SHISX or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both SHISX and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.